entity

CAA pathology

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CAA pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
0Hypotheses
1Analyses
2Outgoing
3Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
cognitive declinerisk_factor_forphenotype0.90
VSMC degenerationcausesprocess0.70

Incoming (3)

SourceRelationTypeStr
VSMC-mediated Aβ clearancepreventsprocess0.90
VSMC autophagy impairmentcausesprocess0.70
P2RY12regulatesgene0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

How does P2RY12-mediated VSMC dysfunction contribute to cerebrovascular neurodeg

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.605

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While the study establishes P2RY12's role in VSMC foam cell formation in atheros

closed · Rounds: 4 · Score: 0.62 · 2026-04-21

Related Research

Hypotheses and analyses mentioning CAA pathology in their description or question text

No additional research found